Olympus Corp. (DE:OLY1)

FRANKFURT:OLY1

OLY1

Olympus

RESEARCH TOOLSreports

Olympus (OLY1) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

OLY1 Analyst Ratings

Moderate Buy

2 Buy

0 Hold

0 Sell

Based on 2 analysts giving stock ratings to

Olympus

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

OLY1 Stock 12 Month Forecast

Average Price Target

€11.44

▲(37.18% Upside)

Based on 2 Wall Street analysts offering 12 month price targets for Olympus in the last 3 months. The average price target is €11.44 with a high forecast of €12.38 and a low forecast of €10.50. The average price target represents a 37.18% change from the last price of €8.34.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"€6","13":"€13","7.75":"€7.75","9.5":"€9.5","11.25":"€11.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12.3832,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€12.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.440999999999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€11.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.4988,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€10.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,7.75,9.5,11.25,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.606,9.81963076923077,10.033261538461538,10.246892307692308,10.460523076923076,10.674153846153846,10.887784615384616,11.101415384615384,11.315046153846154,11.528676923076922,11.742307692307692,11.955938461538462,12.16956923076923,{"y":12.3832,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.606,9.747153846153847,9.888307692307691,10.029461538461538,10.170615384615385,10.31176923076923,10.452923076923076,10.594076923076923,10.735230769230768,10.876384615384614,11.01753846153846,11.158692307692306,11.299846153846152,{"y":11.440999999999999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,9.606,9.674676923076923,9.743353846153846,9.81203076923077,9.880707692307691,9.949384615384615,10.018061538461538,10.086738461538461,10.155415384615385,10.224092307692308,10.29276923076923,10.361446153846153,10.430123076923076,{"y":10.4988,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.915,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.807,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.096,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.126,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.214,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.287,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.13,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.523,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":9.822,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":7.883,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":8.65,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.144,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.606,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€12.38

Average Price Target€11.44

Lowest Price Target€10.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stephen Barker

Jefferies

€9.15→€12.38

Buy

48.48%

Upside

Upgraded

05/18/26

Olympus upgraded to Buy from Hold at JefferiesOlympus upgraded to Buy from Hold at Jefferies

Unknown Analyst

Goldman Sachs

Not Ranked

Goldman Sachs

€12.11→€10.5

Buy

25.88%

Upside

Reiterated

04/15/26

Goldman Sachs Sticks to Its Buy Rating for Olympus (OCPNF)

Tony Ren

Macquarie

€10.77

Hold

29.11%

Upside

Reiterated

10/14/25

Macquarie Sticks to Its Hold Rating for Olympus (OCPNF)

Naoko Saito

J.P. Morgan

€12.65→€11.31

Buy

35.57%

Upside

Reiterated

10/02/25

Olympus (OCPNF) Receives a Buy from J.P. Morgan

Ryotaro Hayashi

Morgan Stanley

€10.77

Buy

29.11%

Upside

Reiterated

06/28/25

Morgan Stanley Keeps Their Buy Rating on Olympus (OCPNF)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stephen Barker

Jefferies

€9.15→€12.38

Buy

48.48%

Upside

Upgraded

05/18/26

Olympus upgraded to Buy from Hold at JefferiesOlympus upgraded to Buy from Hold at Jefferies

Unknown Analyst

Goldman Sachs

Not Ranked

Goldman Sachs

€12.11→€10.5

Buy

25.88%

Upside

Reiterated

04/15/26

Goldman Sachs Sticks to Its Buy Rating for Olympus (OCPNF)

Tony Ren

Macquarie

€10.77

Hold

29.11%

Upside

Reiterated

10/14/25

Macquarie Sticks to Its Hold Rating for Olympus (OCPNF)

Naoko Saito

J.P. Morgan

€12.65→€11.31

Buy

35.57%

Upside

Reiterated

10/02/25

Olympus (OCPNF) Receives a Buy from J.P. Morgan

Ryotaro Hayashi

Morgan Stanley

€10.77

Buy

29.11%

Upside

Reiterated

06/28/25

Morgan Stanley Keeps Their Buy Rating on Olympus (OCPNF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Olympus

3 Months

DeepSeek Medical - Instruments and SuppliesTipRanks - DeepSeek

Success Rate

2/3 ratings generated profit

Average Return

+4.07%

Copying DeepSeek Medical - Instruments and Supplies's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +4.07% per trade.

1 Year

DeepSeek Medical - Instruments and SuppliesTipRanks - DeepSeek

Success Rate

2/3 ratings generated profit

Average Return

+4.07%

Copying DeepSeek Medical - Instruments and Supplies's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +4.07% per trade.

2 Years

DeepSeek Medical - Instruments and SuppliesTipRanks - DeepSeek

Success Rate

2/3 ratings generated profit

Average Return

+4.07%

Copying DeepSeek Medical - Instruments and Supplies's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +4.07% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OLY1 Analyst Recommendation Trends

Rating

Feb 26

Mar 26

Apr 26

May 26

Jun 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, OLY1 has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. OLY1 average Analyst price target in the past 3 months is 11.44.

Each month's total comprises the sum of three months' worth of ratings.

OLY1 Financial Forecast

OLY1 Earnings Forecast

Next quarter’s earnings estimate for OLY1 is €0.05 with a range of €0.04 to €0.08. The previous quarter’s EPS was €0.12. OLY1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year OLY1 has Performed in-line its overall industry.

OLY1 Sales Forecast

Next quarter’s sales forecast for OLY1 is €1.22B with a range of €1.12B to €1.29B. The previous quarter’s sales results were €1.59B. OLY1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year OLY1 has Performed in-line its overall industry.

OLY1 Stock Forecast FAQ

What is DE:OLY1’s average 12-month price target, according to analysts?

Based on analyst ratings, Olympus Corp.’s 12-month average price target is 11.44.

What is DE:OLY1’s upside potential, based on the analysts’ average price target?

Olympus Corp. has 37.18% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Olympus Corp. a Buy, Sell or Hold?

Olympus Corp. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.

What is Olympus Corp.’s share price target?

The average share price target for Olympus Corp. is 11.44. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €12.38 ,and the lowest forecast is €10.50. The average share price target represents 37.18% Increase from the current price of €8.34.

What do analysts say about Olympus Corp.?

Olympus Corp.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.

How can I buy shares of Olympus Corp.?

To buy shares of DE:OLY1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Olympus (OLY1) Stock Forecast & Price Target

OLY1 Analyst Ratings

OLY1 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Olympus

OLY1 Analyst Recommendation Trends

OLY1 Financial Forecast

OLY1 Earnings Forecast

OLY1 Sales Forecast

OLY1 Stock Forecast FAQ

Detailed List of Analyst Forecasts